Publications from Johnson & Johnson, page 4
A filtered view. Show the full list.
Refine
Listings
-
ArticleCell
Human genetics guides the discovery of CARD9 inhibitors with anti-inflammatory activity
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
Disease researchAdded
-
ArticleCell reports
Combining genotoxic gut bacterial strains increases tumor burden and accelerates onset in a germ-free mouse model of colon carcinogenesis
Listed An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
Disease researchAdded
-
ArticleClinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
No Impact of Low-Dose Nivolumab Addition to JNJ-73763989 on Hepatitis B Surface Antigen Declines in Chronic Hepatitis B: The OCTOPUS-1 Study
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
Clinical careAdded
-
ArticleCell host & microbe
Defined human Clostridia consortia reverse colitis via dual effects of tryptophan metabolites on microbiota and immunity
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
Disease researchAdded
-
ArticleCHEST pulmonary
Expert Consensus to Explore the Definition and Characterization of Methamphetamine-Associated Pulmonary Arterial Hypertension and Key Treatment Considerations
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
Clinical careAdded
-
ArticleCJC open
Real-world Persistence on Selexipag for Pulmonary Arterial Hypertension in Canada
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
Clinical careAdded
-
ArticleClinical therapeutics
Antipsychotic Treatment Pathways, Real-World Adherence, Healthcare Resource Utilization, and Healthcare Costs Among Patients With Schizophrenia Treated With Once-Monthly, Once-Every-Three-Months, and Once-Every-Six-Months Paliperidone Palmitate in the United States
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
Clinical careAdded
-
Clinical trial reportClinical lung cancer
Patient-Relevant Outcomes From the Phase III MARIPOSA-2 Trial: Amivantamab-Chemotherapy Versus Chemotherapy in EGFR-Mutant Advanced Non-Small-Cell Lung Cancer Following Disease Progression on Osimertinib
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
Clinical careAdded
-
Clinical trial reportClinical lung cancer
Subcutaneous Delivery of Amivantamab in Patients With Advanced Solid Malignancies: The Phase Ib PALOMA Study
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
Clinical careAdded
-
ArticleClinical lymphoma, myeloma & leukemia
Relative Effectiveness of Talquetamab Versus Real-World Physician's Choice Treatment Regimens in Patients With Relapsed/Refractory Multiple Myeloma: Updated Results From an Indirect Treatment Comparison
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
Clinical careAdded
-
ReviewClinical lymphoma, myeloma & leukemia
Real-World Evidence on Ibrutinib in First-Line Chronic Lymphocytic Leukemia/ Small Lymphocytic Lymphoma: A Comprehensive Review
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
Clinical careAdded
-
ReviewClinical lymphoma, myeloma & leukemia
Choosing Wisely in First Relapse of Multiple Myeloma: Expert Insights on Treatment Selection
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
Clinical careAdded
-
ArticleClinical lymphoma, myeloma & leukemia
Real-World Treatment Patterns and Outcomes for Patients With Relapsed/Refractory Multiple Myeloma and Prior Exposure to Lenalidomide and Proteasome Inhibitors in the United States
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
Clinical careAdded
-
ReviewClinical lymphoma, myeloma & leukemia
Non-ICANS Neurologic Events in Patients With Relapsed/Refractory Multiple Myeloma Treated With Ciltacabtagene Autoleucel: Clinical Presentation and Management in CARTITUDE Studies
Verified Author affiliations on the Europe PMC record name Johnson & Johnson, Perelman School of Medicine, University of Pennsylvania. Affiliation source
Clinical careAdded
-
ArticleClinical lymphoma, myeloma & leukemia
Teclistamab Response- and Relapse-Related Immune Correlates in the MajesTEC-1 China Cohort
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
Disease researchAdded
-
ReviewDrug metabolism and disposition: the biological fate of chemicals
A review on integrated machine learning and deep learning driven artificial intelligence models for pharmacokinetics and toxicokinetics predictions, and their application
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
-
ArticleDrug metabolism and disposition: the biological fate of chemicals
Drug-drug interaction assessments of clinical transporter inhibition: Learnings from the Transporter Working Group of the International Consortium for Innovation and Quality in Pharmaceutical Development
Verified Author affiliations on the Europe PMC record name GSK, Johnson & Johnson. Affiliation source
-
ArticleDrug metabolism and disposition: the biological fate of chemicals
Metabolism and excretion pathways of CD388, a novel drug-fragment crystallizable conjugate for prevention of seasonal or pandemic influenza
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
-
ArticleDrug metabolism and disposition: the biological fate of chemicals
In vitro reversible enzyme inhibition assays to predict drug-drug interactions: Current state and industry perspective from the IQ Consortium Enzyme Inhibition Working Group
Verified Author affiliations on the Europe PMC record name GSK, Johnson & Johnson. Affiliation source
-
ArticleDrug metabolism and disposition: the biological fate of chemicals
Breaking the 1% unbound threshold: an IQ consortium whitepaper on the evaluation of plasma protein binding of highly bound compounds
Verified Author affiliations on the Europe PMC record name GSK, Johnson & Johnson, Merck & Co. Affiliation source
-
ReviewDrug metabolism and pharmacokinetics
Future directions in drug-drug interaction evaluations: Industry perspective on the ICH M12 guidance
Verified Author affiliations on the Europe PMC record name Bristol Myers Squibb, GSK, Johnson & Johnson. Affiliation source
-
Clinical trial reportEuropean journal of cancer (Oxford, England : 1990)
Assessing time to symptomatic progression, a patient-relevant efficacy endpoint, in the MARIPOSA study in non-small cell lung cancer
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
Clinical careAdded
-
ReviewEULAR rheumatology open
From pixels to prediction: improving imaging through AI in rheumatology
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
Medical imagingAdded
-
Clinical trial reportESMO open
Full enrollment results from cohort 1 of the phase III randomized THOR trial of erdafitinib versus chemotherapy in FGFR-altered advanced urothelial carcinoma
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
Clinical careAdded